Femasys Inc. Gains 130.77%
Thu, Jul 27, 2023 at 07:37 PM
Femasys Inc. (FEMY:NASDAQ) shot up at $0.84, representing a gain of 130.8%. On Thu, Jul 27, 2023, FEMY:NASDAQ touched a New 2-Week High of $0.84. The stock got featured on our News Catalysts scanner on Thu, Jul 27, 2023 at 10:56 AM in the 'PATENT' category. From Thu, Jul 13, 2023, the stock recorded 30.00% Up Days and 27.27% Green Days
The stock spiked on Thu, Jul 27, 2023 at $1.05 with a volume of 172M+.
About Femasys Inc. (FEMY:NASDAQ)
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas.
Top 10 Gainers:
- Statera Biopharma Inc. (STAB:NASDAQ), 616.67%
- Femasys Inc. (FEMY:NASDAQ), 130.77%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 105%
- UroGen Pharma Ltd. (URGN:NASDAQ), 98.56%
- Greenbrook TMS Inc. (GBNH:NASDAQ), 90.38%
- Tupperware Brands Corporation (TUP:NYSE), 56.32%
- Colombier Acquisition Corp. Class A (CLBR:NYSE), 54.51%
- Ultralife Corporation (ULBI:NASDAQ), 52.54%
- Carmell Therapeutics Corporation Class A Common Stock (CTCX:NASDAQ), 46%
- View Inc. (VIEW:NASDAQ), 44.36%